Lupin gets USFDA nod for generic equivalent of Mylan Specialty Perforomist Inhalation Solution Ruchika Sharma24 Aug 2022 5:00 PM ISTPERFOROMIST Inhalation Solution is a long-acting beta2-adrenergic agonist (beta2-agonist)
Lupin bags USFDA okay for seizure treatment drug Rufinamide Ruchika Sharma18 Aug 2022 3:23 PM ISTRufinamide Tablets will be manufactured at Lupin’s facility in Goa, India.
Lupin rationalising product portfolio in US to overcome price erosion impact, says CEO Vinita Gupta Ruchika Sharma16 Aug 2022 1:30 PM ISTLupin's transitioning of the portfolio from the simple generic oral solids to complex generics had started with short-acting bronchodilator albuterol.
Lupin bags USFDA nod for Meclizine Hydrochloride Tablets Ruchika Sharma13 Aug 2022 1:00 PM ISTThe product is a generic equivalent of Antivert Tablets, 12.5 mg, 25 mg, and 50 mg, of Casper Pharma LLC.
Lupin secures USFDA nod for Azilsartan Medoxomil Tablets Ruchika Sharma25 July 2022 5:46 PM ISTThe product will be manufactured at Lupin’s facility in Nagpur, India.
Lupin Somerset facility gets EIR from USFDA Rahul Verma9 July 2022 6:30 PM ISTGlobal pharma major, Lupin Limited, today announced that the company has received the Establishment Inspection Report (EIR) from United States Food...
Lupin gets USFDA EIR for Somerset facility Ruchika Sharma7 July 2022 11:30 AM ISTThe USFDA has determined that the inspection classification of the facility is Voluntary Action Indicated (VAI).
Lupin gets USFDA nod for generic equivalent of Invega ER Tablets Ruchika Sharma1 July 2022 12:30 PM ISTThe product will be manufactured at Lupin’s facility in Goa, India.
Lupin, Accenture collaborate to accelerate business efficacy with data driven competencies Ruchika Sharma20 Jun 2022 1:30 PM IST"SAP Fiori apps have helped enhance the user experience for Lupin employees with simple and easy-to access data models and analytical reports," the...
Lupin Diagnostics opens Regional Reference Laboratory in Patna Ruchika Sharma15 Jun 2022 4:53 PM IST"By establishing a presence in Patna, the company now looks forward to making a deeper foray into Bihar," the company said.
Lupin bags USFDA nod for cystic fibrosis drug Ivacaftor Ruchika Sharma8 Jun 2022 2:47 PM ISTThis product will be manufactured at Lupin’s Nagpur facility in India.
USFDA nod to Lupin Iloperidone tablets Ruchika Sharma7 May 2022 12:36 PM ISTMumbai: Lupin Limited has recently announced that the company has received approval from the United States Food and Drug Administration (USFDA) for...
